EcoR1 Capital as of March 31, 2024
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 57 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 16.9 | $668M | 11M | 58.78 | |
| Prothena Corp SHS (PRTA) | 7.3 | $287M | 12M | 24.77 | |
| Arvinas Ord (ARVN) | 7.0 | $278M | 6.7M | 41.28 | |
| Sarepta Therapeutics (SRPT) | 6.3 | $249M | 1.9M | 129.46 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.9 | $195M | 4.2M | 46.81 | |
| Galapagos Nv Spon Adr (GLPG) | 4.7 | $185M | 5.8M | 32.20 | |
| Anaptysbio Inc Common (ANAB) | 4.3 | $169M | 7.5M | 22.52 | |
| Zymeworks Del (ZYME) | 3.6 | $141M | 13M | 10.52 | |
| Kura Oncology (KURA) | 3.5 | $139M | 6.5M | 21.33 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.1 | $122M | 1.0M | 120.42 | |
| Xencor (XNCR) | 3.0 | $118M | 5.3M | 22.13 | |
| ACADIA Pharmaceuticals (ACAD) | 2.8 | $111M | 6.0M | 18.49 | |
| Tango Therapeutics (TNGX) | 2.7 | $106M | 13M | 7.94 | |
| Immunome (IMNM) | 2.4 | $96M | 3.9M | 24.68 | |
| Crispr Therapeutics Namen Akt (CRSP) | 2.4 | $95M | 1.4M | 68.16 | |
| Mersana Therapeutics (MRSN) | 2.2 | $87M | 19M | 4.48 | |
| Morphic Hldg (MORF) | 2.1 | $84M | 2.4M | 35.20 | |
| Nuvation Bio Com Cl A (NUVB) | 1.8 | $70M | 19M | 3.64 | |
| Neurogene (NGNE) | 1.6 | $65M | 1.3M | 50.90 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.6 | $64M | 5.6M | 11.30 | |
| Oric Pharmaceuticals (ORIC) | 1.2 | $47M | 3.4M | 13.75 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.1 | $43M | 27M | 1.58 | |
| Tscan Therapeutics (TCRX) | 1.0 | $40M | 5.0M | 7.94 | |
| Voyager Therapeutics (VYGR) | 0.9 | $37M | 3.9M | 9.31 | |
| Third Harmonic Bio (THRD) | 0.8 | $30M | 3.2M | 9.44 | |
| Neumora Therapeutics (NMRA) | 0.7 | $29M | 2.1M | 13.75 | |
| Celldex Therapeutics Com New (CLDX) | 0.7 | $27M | 650k | 41.97 | |
| Iteos Therapeutics (ITOS) | 0.7 | $27M | 2.0M | 13.64 | |
| Lenz Therapeutics Com Added | 0.7 | $27M | 1.2M | 22.33 | |
| Atea Pharmaceuticals (AVIR) | 0.6 | $25M | 6.1M | 4.04 | |
| Alector (ALEC) | 0.6 | $24M | 4.1M | 6.02 | |
| Edgewise Therapeutics (EWTX) | 0.6 | $23M | 1.3M | 18.24 | |
| Nkarta (NKTX) | 0.5 | $22M | 2.0M | 10.81 | |
| Pharvaris N V (PHVS) | 0.5 | $21M | 900k | 23.11 | |
| Vaxcyte (PCVX) | 0.5 | $21M | 300k | 68.31 | |
| Madrigal Pharmaceuticals (MDGL) | 0.5 | $20M | 75k | 267.04 | |
| Avidity Biosciences Ord (RNA) | 0.5 | $19M | 758k | 25.52 | |
| Ovid Therapeutics (OVID) | 0.5 | $19M | 6.1M | 3.05 | |
| Verve Therapeutics (VERV) | 0.4 | $17M | 1.3M | 13.28 | |
| Keros Therapeutics (KROS) | 0.3 | $12M | 188k | 66.20 | |
| Dyne Therapeutics (DYN) | 0.3 | $12M | 427k | 28.39 | |
| Kyverna Therapeutics Com Added | 0.3 | $11M | 450k | 24.84 | |
| Gossamer Bio (GOSS) | 0.3 | $11M | 9.2M | 1.18 | |
| Kodiak Sciences (KOD) | 0.2 | $8.8M | 1.7M | 5.26 | |
| Allovir (ALVR) | 0.2 | $8.5M | 11M | 0.75 | |
| Generation Bio (GBIO) | 0.2 | $8.3M | 2.0M | 4.07 | |
| Atara Biotherapeutics (ATRA) | 0.2 | $7.1M | 10M | 0.69 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.2 | $6.6M | 2.9M | 2.29 | |
| Aligos Therapeutics (ALGS) | 0.2 | $6.3M | 6.4M | 0.98 | |
| Arcutis Biotherapeutics (ARQT) | 0.1 | $5.0M | 500k | 9.91 | |
| Prime Medicine (PRME) | 0.1 | $4.9M | 700k | 7.00 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.1 | $3.5M | 963k | 3.64 | |
| Hookipa Pharma Inc equity (HOOK) | 0.1 | $3.3M | 4.6M | 0.71 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.0M | 67k | 15.71 | |
| Pmv Pharmaceuticals (PMVP) | 0.0 | $964k | 567k | 1.70 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $482k | 100k | 4.82 | |
| Alpine Immune Sciences (ALPN) | 0.0 | $40k | 1.0k | 39.64 |
